A recent Politico article noted that Pfizer and its partner BioNTech are seeking full approval from the FDA for their Covid-19 vaccine for people 16 and older. The two-dose protection against coronavirus received emergency use authorization earlier this year, which allowed it to be one of three vaccines used in the pandemic battle. Full approval means the companies would be able to market the shot directly to consumers, and make it easier for schools, employers, and the military to require vaccination against Covid-19.
Pfizer Eyes Full FDA Approval for Covid-19 Vaccine
Pfizer and partner BioNTech are the first vaccine manufacturers to seek full approval in the U.S.
May 10, 2021
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
